According to Cullinan Therapeutics's latest financial reports the company's current EPS (TTM) is -3,84ย โฌ. In 2022 the company made an earnings per share (EPS) of 2,39ย โฌ an increase over its 2021 EPS that were of -1,44ย โฌ.